All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Aging
    • Biosimilars
    • Artificial intelligence
    • Coronavirus
    • IVDs on the rise
    • Radiopharmaceuticals
    • Science '22 in Review
    • Top Biopharma Trends of 2022
    • Top Med-tech Trends of 2022
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • sign in
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, June 10, 2023
Home » Topics » Infection » Coronavirus

Coronavirus
Coronavirus RSS Feed RSS

Future imperfect: CBER head weighs good-enough options in virus war

April 20, 2020
By Randy Osborne
No Comments
Looking ahead to COVID-19 strategies, Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research (CBER), said vaccine studies might be done not in clinics but in the streets. “By definition, we’re probably not going to be able to vaccinate everyone simultaneously,” he noted.
Read More
United Kingdom flag, map

U.K. pitches £500M bailout for VC-backed firms

April 20, 2020
By Nuala Moran
No Comments
LONDON – The U.K. treasury announced a £500 million (US$622.5 million) COVID-19 bailout plan for research-based startups, which could see the government holding equity stakes in venture capital-backed firms.
Read More

Week in review for April 13-17, 2020: Biopharmas gain new product approvals

April 20, 2020
No Comments
A quick look back at top stories.
Read More

Regulatory actions for April 20, 2020

April 20, 2020
No Comments
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: 4D, Futura, Genentech, Mustang, Precigen.
Read More

Other news to note for April 20, 2020

April 20, 2020
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Alligator, Anixa, Bayer, CB, Chromadex, Compugen, Cue, Cyclacel, Epsilogen, Esperion, Helsinn, Inmune, Innocan, Melinta, Merck, Molecular Partners, Noxxon, Otsuka, Recce Pharmaceuticals, Som Biotech, Theravance Biopharma.
Read More

In the clinic for April 20, 2020

April 20, 2020
No Comments
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alexion, Ascendis, BMS, Idorsia, Incyte, Karyopharm, Novartis, Xeris.
Read More
4-17-intuitive-da-vinci.png

Intuitive climbs on earnings, but cautious on growth in procedures, hospital sales

April 17, 2020
By Stacy Lawrence
No Comments
Robotic-assisted surgical procedures have fallen off steeply as the ongoing global pandemic has unfolded, but the real impact on Intuitive Surgical Inc. will come as its hospital customers may have to limit orders for expensive equipment upgrades as they struggle to manage unprecedented financial burdens. The U.S. accounts for about 70% of its robotic surgery procedures, but by the last few weeks in March, that activity had been curtailed by roughly two-thirds.
Read More

Regulatory front for April 17, 2020

April 17, 2020
No Comments
The latest global regulatory news, changes and updates affecting medical devices and technologies, including: J1 Medical.
Read More

Regulatory actions for April 17, 2020

April 17, 2020
No Comments
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Cirrusdx, Curative, Vent Multiplexor.
Read More

Other news to note for April 17, 2020

April 17, 2020
No Comments
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Applied Biosystems, Assistek, Chronically Simple, Debiotech, Genetic Technologies, Gold Standard Diagnostics Group, Inform Diagnostics, Intelligent Fingerprinting, Kraig Biocraft, Masimo, Medmira, Promega, Qventus, Roche, Rxmx, Samsung, Sanvello, True Diagnostics, Veracyte, Veravas.
Read More
Previous 1 2 … 441 442 443 444 445 446 447 448 449 … 511 512 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 9, 2023.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for June 9, 2023.
  • Medical cannabis in blister pack of capsules

    Zelira’s stock triples as cannabinoid outperforms Lyrica in pain

    BioWorld
    Medicinal cannabis company Zelira Therapeutics Ltd.’s stock shot up 224% on May 31 on the heels of news that its cannabinoid product, ZLT-L-007, outperformed...
  • Gavel and First Amendment

    Citing US constitutional violations, Merck the first to challenge the IRA

    BioWorld
    The question wasn’t if, but when and how, someone would challenge the Medicare negotiation provision laid out in the Inflation Reduction Act (IRA) that was signed...
  • Cerebellum, brain stem, spinal cord

    Reprocell reports mixed results for phase II Stemchymal trial in spinocerebellar ataxia

    BioWorld
    Regenerative medicine product Stemchymal, an allogeneic adipose-derived mesenchymal stem cell treatment, missed the primary efficacy endpoints in two phase II...
black cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
Follow Us

Copyright ©2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing